BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36001283)

  • 21. Comparison of the 8th UICC staging system for esophageal and gastric cancers in Siewert type II junctional adenocarcinomas.
    Karstens KF; Ghadban T; Sawez S; Konczalla L; Woestemeier A; Bachmann K; Uzunoglu FG; Tachezy M; Vettorazzi E; Izbicki JR; Reeh M
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):638-643. PubMed ID: 31879051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment Strategy for Esophagogastric Junction Carcinoma;Highly Controversial Topic in the Upper Gastrointestinal Malignancy].
    Yamashita H; Seto Y
    Kyobu Geka; 2017 Jan; 70(1):72-79. PubMed ID: 28174399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications.
    Driessen A; Nafteux P; Lerut T; Van Raemdonck D; De Leyn P; Filez L; Penninckx F; Geboes K; Ectors N
    Mod Pathol; 2004 Jan; 17(1):49-55. PubMed ID: 14631371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus.
    Cameron AJ; Lomboy CT; Pera M; Carpenter HA
    Gastroenterology; 1995 Nov; 109(5):1541-6. PubMed ID: 7557137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.
    Jovanovic I; Tzardi M; Mouzas IA; Micev M; Pesko P; Milosavljevic T; Zois M; Sganzos M; Delides G; Kanavaros P
    Histol Histopathol; 2002 Apr; 17(2):445-54. PubMed ID: 11962749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.
    Yuasa N; Miyake H; Yamada T; Ebata T; Nimura Y; Hattori T
    World J Surg; 2006 Mar; 30(3):364-71. PubMed ID: 16485063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma.
    Ormsby AH; Goldblum JR; Rice TW; Richter JE; Gramlich TL
    Histopathology; 2001 Apr; 38(4):307-11. PubMed ID: 11318895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of p53 protein in Barrett's adenocarcinoma and adenocarcinoma of the gastric cardia and antrum.
    Jovanović I; Todorović V; Milosavljević T; Micev M; Pesko P; Bjelović M; Mouzas Y; Tzardi M
    Vojnosanit Pregl; 2005 Dec; 62(12):879-85. PubMed ID: 16375215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction.
    Marsman WA; Tytgat GN; ten Kate FJ; van Lanschot JJ
    J Surg Oncol; 2005 Dec; 92(3):160-8. PubMed ID: 16299781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
    Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
    Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors.
    Sakaki A; Kanamori J; Ishiyama K; Kurita D; Oguma J; Daiko H
    Langenbecks Arch Surg; 2020 Jun; 405(4):509-519. PubMed ID: 32514766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
    BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.
    Duhaylongsod FG; Wolfe WG
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):36-41; discussion 41-2. PubMed ID: 2072727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases.
    Harada K; Hwang H; Wang X; Abdelhakeem A; Iwatsuki M; Murphy MAB; Maru DM; Weston B; Lee JH; Rogers JE; Trail A; Shanbhag N; Zhao M; Bhutani MS; Nguyen QN; Swisher SG; Ikoma N; Das P; Hofstetter WL; Badgwell BD; Ajani JA
    Gastric Cancer; 2020 Sep; 23(5):904-912. PubMed ID: 32347396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.